Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$825K Sell
180,628
-8,939,649
-98% -$42.6M 0.3% 14
2018
Q2
$42.2M Sell
9,120,277
-5,572
-0.1% -$32.7K 0.75% 12
2018
Q1
$66.3M Hold
9,125,849
1.09% 11
2017
Q4
$59M Sell
9,125,849
-100
-0% -$640 0.77% 12
2017
Q3
$60.1M Sell
9,125,949
-124,813
-1% -$773K 0.77% 12
2017
Q2
$50.8M Sell
9,250,762
-180,387
-2% -$1.03M 0.65% 12
2017
Q1
$54.3M Sell
9,431,149
-385,614
-4% -$2.12M 0.74% 12
2016
Q4
$48.2M Sell
9,816,763
-122,595
-1% -$662K 0.71% 12
2016
Q3
$58.6M Sell
9,939,358
-53,320
-0.5% -$319K 0.97% 11
2016
Q2
$59.1M Sell
9,992,678
-7,322
-0.1% -$39.3K 0.86% 11
2016
Q1
$55.9M Buy
+10,000,000
New +$46M 0.82% 11

Other funds holding ABEV

Northern Cross's ABEV Position: Q3 2018 in Review

Northern Cross reduced its Ambev (ABEV) stake by 98% in Q3 2018, selling an estimated $42.6M and leaving 180,628 shares worth $825K. The position accounts for 0.3% of the portfolio, ranked #14.

Northern Cross first reported a position in ABEV in Q1 2016 and has held it in 11 quarters since. The position peaked at $66.3M in Q1 2018. 330 funds tracked by Wall St. Rank hold ABEV as of Q3 2018.

  • Northern Cross held 180,628 shares of Ambev worth $825K as of Q3 2018.
  • Northern Cross sold 8,939,649 Ambev shares in Q3 2018, an estimated $42.6M.
  • Ambev made up 0.3% of Northern Cross's portfolio in Q3 2018, its #14 holding.
  • Northern Cross first reported a position in Ambev in Q1 2016 and has held it in 11 quarters since.
  • Northern Cross's Ambev position peaked at $66.3M in Q1 2018.
  • 330 funds tracked by Wall St. Rank held Ambev as of Q3 2018.

Based on Northern Cross's 13F filing for Q3 2018, filed 9 Nov 2018.